Literature DB >> 22450503

[Computerized tomography utilization for stroke inpatients in the Brazilian Health System].

Cristina Lúcia Rocha Cubas Rolim1, Monica Martins.   

Abstract

Stroke is a leading reason for hospitalization in the Brazilian Health System. Computerized tomography has been indicated as the main diagnostic method to define stroke treatment. The aim of this paper was to evaluate the utilization of computerized tomography in hospitalizations due to stroke. The source of data was the Brazilian hospital information system. The study population comprised adult stroke inpatients in Brazil in the Brazilian Health System, between April 2006 and December 2007. Data analysis was descriptive for stroke and for each separate subgroup. Of the 328,087 stroke inpatients, 73.5% had not done a computerized tomography scan. Among hospitalizations that underwent a computed tomography scan, 22.3% had access to one test, and only 4.2% had two tests. Besides underuse, the computed tomography scans performed did not improve the encoding of the disease subgroup.

Entities:  

Mesh:

Year:  2012        PMID: 22450503     DOI: 10.1590/s1415-790x2012000100016

Source DB:  PubMed          Journal:  Rev Bras Epidemiol        ISSN: 1415-790X


  3 in total

1.  Hospitalization of the aged due to stroke: An ecological perspective.

Authors:  Marcelo de Jesus Carlos; Ana Carolina Lima Cavaletti; Célia Pereira Caldas
Journal:  PLoS One       Date:  2019-08-07       Impact factor: 3.240

2.  Hospital mortality in older patients in the Brazilian Unified Health System, Southeast region.

Authors:  Paula Cordeiro; Mônica Martins
Journal:  Rev Saude Publica       Date:  2018-07-23       Impact factor: 2.106

3.  Incidence of hospitalization and mortality due to stroke in young adults, residents of developed regions in Brazil, 2008-2018.

Authors:  Henrique de Moraes Bernal; Luiz Carlos de Abreu; Italla Maria Pinheiro Bezerra; Fernando Adami; Jessica Miwa Takasu; João Victor Ji Young Suh; Silmara de Lira Ribeiro; Edige Felipe de Sousa Santos
Journal:  PLoS One       Date:  2020-11-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.